Charlie Searle, Associate
Charlie advises a broad range of UK and international individuals and trustees in relation to UK tax, trusts and succession planning.
Contact Charlie
-
+44 (0) 20 7438 2193
Tel
-
Email Charlie
Email: charlie.searle@crsblaw.com
- View Charlie's LinkedIn Profile
- Download vCard
- London office
Service:
About
He has experience drafting Wills and trust documentation, as well as advising on tax law, asset protection and estate planning opportunities.
Our thinking
Charlie Searle
Everything you need to know about the Spring Statement
Find out everything you need to know about Rishi Sunak's Spring Statement that was released today.
Charlie Searle
Wealth tax – will the UK be richer for it?
It is no secret that the Chancellor will need to raise revenue from somewhere to plug the growing budget deficit.
Capital Gains Tax - Is change afoot?
Charlie Searle
Capital Gains Tax – is change afoot?
The Office of Tax Simplification has published its first report into the review of capital gains tax (CGT) reform.
Charlie Searle
“Every step of life shows much caution is required” - thoughts on virtual witnessing of Wills
The COVID-19 pandemic has jolted many into action to consider whether their affairs are in order.
Charlie Searle
Entrepreneurs' Relief
Charlie Searle discusses Entrepreneurs' Relief and proposed reform.
Charlie Searle
To Be an Easement or Not to Be
A look at the recent decision in Churston Golf Club Ltd v Haddock
Ashwin Pillay
Charles Russell Speechlys advises Civica on the acquisition of TranSend Solutions Ltd
TranSend Solutions is a leading provider of delivery management software to organisations with complex logistics and transport requirements.
David Coates
Charles Russell Speechlys advises Stonegate Pub Company on its acquisition of Bar Fever Limited and six sites from Novus Leisure
Stonegate Pub Company has acquired Bar Fever Limited, which operates 32 venues located in towns and cities throughout England.
Charlie Searle
Charles Russell Speechlys advises Kreos and SVB on £20m growth capital investment to Mereo BioPharma
We advised Kreos Capital and Silicon Valley Bank on the refinancing of £20 million growth capital investment to Mereo BioPharma Group